ロード中...
A Case of Immune Checkpoint Inhibitor Refractory Colitis Treated with Mycophenolate and High-dose Steroids
Immune checkpoint inhibitors (ICPI) are a class of chemotherapy agents that have emerged as a front-line treatment option for multiple cancers. Nivolumab is an ICPI agent commonly used to treat metastatic melanoma. Although promising, the adverse reaction of this class is broad and per reports, the...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6957235/ https://ncbi.nlm.nih.gov/pubmed/31938669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.6392 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|